FDA Drug Application (020229) for LEUSTATIN by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number020229
Product Number001
FormINJECTABLE;INJECTION
Dosage1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLEUSTATIN
Active IngredientCLADRIBINE

Active IngredientCount
List of drugs with Active Ingredient CLADRIBINE2


Back to FDA Applications sponsored by JANSSEN PHARMS